{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:41:20Z","timestamp":1777887680165,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijid.2026.108503","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:12:54Z","timestamp":1772093574000},"page":"108503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for the prevention of RSV illness among infants in Hong Kong"],"prefix":"10.1016","volume":"166","author":[{"given":"Victoria","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6331-5497","authenticated-orcid":false,"given":"Robyn","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luka","family":"Ivkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy W.","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10340","key":"10.1016\/j.ijid.2026.108503_bib0001","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108503_sbref0002","author":"Centre for Health Protection of the Department of Health. Interim Consensus on the Use of Respiratory Syncytial Virus Vaccines in Hong Kong (As of 17 January 2025)","year":"2025"},{"issue":"5","key":"10.1016\/j.ijid.2026.108503_bib0003","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcrc.2011.12.001","article-title":"Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis","volume":"27","author":"Hon","year":"2012","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijid.2026.108503_bib0004","unstructured":"Census and Statistics Department. Table 115-01012 : Number of live births born in Hong Kong to Mainland women, https:\/\/www.censtatd.gov.hk\/en\/web_table.html?id=115-01012; [accessed 30 July 2024]."},{"key":"10.1016\/j.ijid.2026.108503_bib0005","unstructured":"WR Johnston. Abortion statistics and other data\u2013Johnston`s Archive, https:\/\/www.johnstonsarchive.net\/policy\/abortion\/ab-hongkong.html; [accessed 30 July 2024]."},{"issue":"46","key":"10.1016\/j.ijid.2026.108503_bib0006","doi-asserted-by":"crossref","first-page":"e2024","DOI":"10.1097\/MD.0000000000002024","article-title":"Hospitalization incidence, mortality, and seasonality of common respiratory viruses over a period of 15 years in a developed subtropical City","volume":"94","author":"Chan","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.ijid.2026.108503_bib0007","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3201\/eid2607.190539","article-title":"Burden and cost of hospitalization for respiratory syncytial virus in young children, Singapore","volume":"26","author":"Tam","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108503_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vaccine.2019.10.023","article-title":"Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants","volume":"38","author":"Rainisch","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108503_bib0009","article-title":"Hospitalizations associated with respiratory syncytial virus among 627 U.S. children <5 years of age","author":"Curns","year":"2022","journal-title":"RSV Symposium"},{"issue":"3","key":"10.1016\/j.ijid.2026.108503_bib0010","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jpids\/piz011","article-title":"Respiratory syncytial virus-associated outpatient visits among children younger than 24 months","volume":"8","author":"Lively","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.ijid.2026.108503_bib0011","unstructured":"Census and Statistics Department. Hong Kong Monthly Digest of Statistics: trends of infant mortality in Hong Kong, 1951 to 2021. https:\/\/www.censtatd.gov.hk\/en\/data\/stat_report\/product\/B1010002\/att\/B10100022023MM05B0100.pdf; 2023 [accessed 1 August 2024]."},{"issue":"5","key":"10.1016\/j.ijid.2026.108503_bib0012","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13145","article-title":"Incidence, hospitalization, and mortality in children aged 5 years and younger with respiratory syncytial virus-related diseases: a systematic review and meta-analysis","volume":"17","author":"Duan","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"10.1016\/j.ijid.2026.108503_bib0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/AOG.0000000000005816","article-title":"Efficacy, safety, and immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F protein vaccine trial","volume":"145","author":"Simoes","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ijid.2026.108503_bib0014","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1473-3099(25)00156-2","volume":"25","author":"Perez Marc","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.108503_bib0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jval.2019.02.014","article-title":"Normative profile of health-related quality of life for Hong Kong general population using preference-based instrument EQ-5D-5L","volume":"22","author":"Wong","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.ijid.2026.108503_bib0016","unstructured":"Hospital Authority. Fees and charges, https:\/\/www.ha.org.hk\/visitor\/ha_visitor_index.asp?Content_ID=10045&Lang=ENG&Dimension=100&Parent_ID=10044; [accessed 30 June 2024]."},{"issue":"46","key":"10.1016\/j.ijid.2026.108503_bib0017","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1016\/j.vaccine.2021.10.009","article-title":"Programme costs for introducing age\/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong","volume":"39","author":"de Haas","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108503_bib0018","unstructured":"World Bank. Part time employment (% of employment), https:\/\/genderdata.worldbank.org\/en\/indicator\/sl-tlf-part-zs; [accessed 31 July 2024]."},{"key":"10.1016\/j.ijid.2026.108503_bib0019","unstructured":"Census and Statistics Department. Wages and labour earnings, https:\/\/www.censtatd.gov.hk\/en\/scode210.html; [accessed 30 June 2024]."},{"key":"10.1016\/j.ijid.2026.108503_bib0020","unstructured":"Census and Statistics Department. Consumer Price Indices (October 2019 \u2013 September 2020 = 100) at COICOP division level, https:\/\/www.censtatd.gov.hk\/en\/web_table.html?id=510-60003; [accessed 20 November 2025]."},{"key":"10.1016\/j.ijid.2026.108503_bib0021","unstructured":"International Monetary Fund. Exchange Rates (ER), https:\/\/data.imf.org\/en\/Data-Explorer?datasetUrn=IMF.STA:ER(4.0.1); 2025 [accessed 20 November 2025]."},{"issue":"6","key":"10.1016\/j.ijid.2026.108503_bib0022","first-page":"699","article-title":"Systematic review of the economic evaluation of influenza vaccines in the Guangdong-Hong Kong-Macao Greater Bay Area_NormalPdf.Pdf>","volume":"34","author":"Mingzheng","year":"2023","journal-title":"China parmacy"},{"key":"10.1016\/j.ijid.2026.108503_bib0023","article-title":"GDP per capita, current prices, U.S","year":"2025","journal-title":"dollars per capita"},{"issue":"1","key":"10.1016\/j.ijid.2026.108503_bib0024","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/14760584.2025.2589208","article-title":"Cost-effectiveness of maternal vaccination against respiratory syncytial virus in Hong Kong: a decision-analytical analysis","volume":"24","author":"Wang","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.ijid.2026.108503_bib0025","article-title":"Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysis","author":"McLachlan","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108503_bib0026","article-title":"Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination","volume":"38","author":"Hodgson","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"10.1016\/j.ijid.2026.108503_bib0027","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jval.2022.11.014","article-title":"Cost-effectiveness of Respiratory syncytial virus preventive interventions in children: a model comparison study","volume":"26","author":"Li","year":"2023","journal-title":"Value Health"},{"issue":"26","key":"10.1016\/j.ijid.2026.108503_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126418","article-title":"Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia","volume":"42","author":"Nazareno","year":"2024","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijid.2026.108503_bib0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0000000000005817","article-title":"Preterm birth frequency and associated outcomes from the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal trial of the bivalent Respiratory syncytial virus prefusion F protein vaccine","volume":"145","author":"Madhi","year":"2025","journal-title":"Obstet Gynecol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:21:00Z","timestamp":1777609260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226001384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"alternative-id":["S1201971226001384"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108503","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for the prevention of RSV illness among infants in Hong Kong","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108503"}}